Medical University Of Silesia Katowice Poland

3 trials 2 recruiting Academic / non-commercial

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

7 Countries active

24 Unique IMPs

100% Results reported

Phase III

Phase IV

Phase III: 2 Phase IV: 1

Oversight events:

1 serious breach across 1 trial

View oversight register →

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

APIXABAN 1 PEMBROLIZUMAB 1

All trials

3 total

SACK Recruiting

2022-501600-10-00 Phase III 7 countries APIXABAN
A Single center, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of neoadjuvant and adjuvant Pembrolizumab on top of standa… Recruiting

2024-517535-52-00 Phase IV 1 country PEMBROLIZUMAB
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Phase III 1 country

Showing 1–3 of 3 trials

← All sponsors A–Z